Review





Similar Products

endometrial samples in rnalater  (Qiagen)
90
Qiagen endometrial samples in rnalater
Endometrial Samples In Rnalater, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endometrial+samples/10__1016_slash_j__rbmo__2024__104697-94-10-16?v=Qiagen
Average 90 stars, based on 1 article reviews
endometrial samples in rnalater - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
endometrial sampling pipette  (MedGyn Products Inc)
90
MedGyn Products Inc endometrial sampling pipette
Endometrial Sampling Pipette, supplied by MedGyn Products Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endometrial+samples/pmc10988946-130-12-12?v=MedGyn+Products+Inc
Average 90 stars, based on 1 article reviews
endometrial sampling pipette - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
microarray endometrial samples  (Illumina Inc)
90
Illumina Inc microarray endometrial samples
Figure 3a. For endometrial secretory samples, POD predicted from the secretory molecular staging model was compared against the full molecular staging model. Note, POD 1 is approximately 58% of the way through the cycle. Figure 3b. Illumina HT-12 <t>microarray</t> data were also available from 198 endometrial samples used to generate the molecular staging model. A validation study was run comparing NGS vs Illumina data. The molecular staging model results showed a strong correlation when comparing the 2 different gene expression platforms. Figure 3c, d. Peripheral blood progesterone ( n = 187) and estrogen ( n = 159) data plotted against the molecular staging model cycle stage showed expected typical menstrual cycle-stage distribution. Source data are provided as a Source Data file.
Microarray Endometrial Samples, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endometrial+samples/pmc10556104-150-17-16?v=Illumina+Inc
Average 90 stars, based on 1 article reviews
microarray endometrial samples - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
endometrial sampling device pipelle #8200  (CooperSurgical)
90
CooperSurgical endometrial sampling device pipelle #8200
Figure 3a. For endometrial secretory samples, POD predicted from the secretory molecular staging model was compared against the full molecular staging model. Note, POD 1 is approximately 58% of the way through the cycle. Figure 3b. Illumina HT-12 <t>microarray</t> data were also available from 198 endometrial samples used to generate the molecular staging model. A validation study was run comparing NGS vs Illumina data. The molecular staging model results showed a strong correlation when comparing the 2 different gene expression platforms. Figure 3c, d. Peripheral blood progesterone ( n = 187) and estrogen ( n = 159) data plotted against the molecular staging model cycle stage showed expected typical menstrual cycle-stage distribution. Source data are provided as a Source Data file.
Endometrial Sampling Device Pipelle #8200, supplied by CooperSurgical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endometrial+samples/pmc10774899-32-12-13?v=CooperSurgical
Average 90 stars, based on 1 article reviews
endometrial sampling device pipelle #8200 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
pipelle endometrial sampling device  (CooperSurgical)
90
CooperSurgical pipelle endometrial sampling device
Figure 3a. For endometrial secretory samples, POD predicted from the secretory molecular staging model was compared against the full molecular staging model. Note, POD 1 is approximately 58% of the way through the cycle. Figure 3b. Illumina HT-12 <t>microarray</t> data were also available from 198 endometrial samples used to generate the molecular staging model. A validation study was run comparing NGS vs Illumina data. The molecular staging model results showed a strong correlation when comparing the 2 different gene expression platforms. Figure 3c, d. Peripheral blood progesterone ( n = 187) and estrogen ( n = 159) data plotted against the molecular staging model cycle stage showed expected typical menstrual cycle-stage distribution. Source data are provided as a Source Data file.
Pipelle Endometrial Sampling Device, supplied by CooperSurgical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endometrial+samples/pm36182264-52-19-15?v=CooperSurgical
Average 90 stars, based on 1 article reviews
pipelle endometrial sampling device - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
endometrial samples  (Thermo Fisher)
99
Thermo Fisher endometrial samples
Figure 3a. For endometrial secretory samples, POD predicted from the secretory molecular staging model was compared against the full molecular staging model. Note, POD 1 is approximately 58% of the way through the cycle. Figure 3b. Illumina HT-12 <t>microarray</t> data were also available from 198 endometrial samples used to generate the molecular staging model. A validation study was run comparing NGS vs Illumina data. The molecular staging model results showed a strong correlation when comparing the 2 different gene expression platforms. Figure 3c, d. Peripheral blood progesterone ( n = 187) and estrogen ( n = 159) data plotted against the molecular staging model cycle stage showed expected typical menstrual cycle-stage distribution. Source data are provided as a Source Data file.
Endometrial Samples, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endometrial+samples/ppr0463397-31-12-15?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
endometrial samples - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
rna-seq of endometrial samples  (Illumina Inc)
90
Illumina Inc rna-seq of endometrial samples
Figure 3a. For endometrial secretory samples, POD predicted from the secretory molecular staging model was compared against the full molecular staging model. Note, POD 1 is approximately 58% of the way through the cycle. Figure 3b. Illumina HT-12 <t>microarray</t> data were also available from 198 endometrial samples used to generate the molecular staging model. A validation study was run comparing NGS vs Illumina data. The molecular staging model results showed a strong correlation when comparing the 2 different gene expression platforms. Figure 3c, d. Peripheral blood progesterone ( n = 187) and estrogen ( n = 159) data plotted against the molecular staging model cycle stage showed expected typical menstrual cycle-stage distribution. Source data are provided as a Source Data file.
Rna Seq Of Endometrial Samples, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endometrial+samples/pmc08722101-212-0-6?v=Illumina+Inc
Average 90 stars, based on 1 article reviews
rna-seq of endometrial samples - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
h&e-stained slides of endometrial biopsy samples  (ProPath Laboratory Inc)
90
ProPath Laboratory Inc h&e-stained slides of endometrial biopsy samples
Figure 3a. For endometrial secretory samples, POD predicted from the secretory molecular staging model was compared against the full molecular staging model. Note, POD 1 is approximately 58% of the way through the cycle. Figure 3b. Illumina HT-12 <t>microarray</t> data were also available from 198 endometrial samples used to generate the molecular staging model. A validation study was run comparing NGS vs Illumina data. The molecular staging model results showed a strong correlation when comparing the 2 different gene expression platforms. Figure 3c, d. Peripheral blood progesterone ( n = 187) and estrogen ( n = 159) data plotted against the molecular staging model cycle stage showed expected typical menstrual cycle-stage distribution. Source data are provided as a Source Data file.
H&E Stained Slides Of Endometrial Biopsy Samples, supplied by ProPath Laboratory Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endometrial+samples/10__1016_slash_j__jpi__2022__100076-3-1-13?v=ProPath+Laboratory+Inc
Average 90 stars, based on 1 article reviews
h&e-stained slides of endometrial biopsy samples - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
normal endometrial and human uspc samples  (Rambam Health Corporation)
90
Rambam Health Corporation normal endometrial and human uspc samples
Figure 3a. For endometrial secretory samples, POD predicted from the secretory molecular staging model was compared against the full molecular staging model. Note, POD 1 is approximately 58% of the way through the cycle. Figure 3b. Illumina HT-12 <t>microarray</t> data were also available from 198 endometrial samples used to generate the molecular staging model. A validation study was run comparing NGS vs Illumina data. The molecular staging model results showed a strong correlation when comparing the 2 different gene expression platforms. Figure 3c, d. Peripheral blood progesterone ( n = 187) and estrogen ( n = 159) data plotted against the molecular staging model cycle stage showed expected typical menstrual cycle-stage distribution. Source data are provided as a Source Data file.
Normal Endometrial And Human Uspc Samples, supplied by Rambam Health Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endometrial+samples/pm34244607-262-4-11?v=Rambam+Health+Corporation
Average 90 stars, based on 1 article reviews
normal endometrial and human uspc samples - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
endometrial tumor samples  (Avaden Bio)
90
Avaden Bio endometrial tumor samples
Figure 3a. For endometrial secretory samples, POD predicted from the secretory molecular staging model was compared against the full molecular staging model. Note, POD 1 is approximately 58% of the way through the cycle. Figure 3b. Illumina HT-12 <t>microarray</t> data were also available from 198 endometrial samples used to generate the molecular staging model. A validation study was run comparing NGS vs Illumina data. The molecular staging model results showed a strong correlation when comparing the 2 different gene expression platforms. Figure 3c, d. Peripheral blood progesterone ( n = 187) and estrogen ( n = 159) data plotted against the molecular staging model cycle stage showed expected typical menstrual cycle-stage distribution. Source data are provided as a Source Data file.
Endometrial Tumor Samples, supplied by Avaden Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endometrial+samples/pm34290245-517-0-6?v=Avaden+Bio
Average 90 stars, based on 1 article reviews
endometrial tumor samples - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Figure 3a. For endometrial secretory samples, POD predicted from the secretory molecular staging model was compared against the full molecular staging model. Note, POD 1 is approximately 58% of the way through the cycle. Figure 3b. Illumina HT-12 microarray data were also available from 198 endometrial samples used to generate the molecular staging model. A validation study was run comparing NGS vs Illumina data. The molecular staging model results showed a strong correlation when comparing the 2 different gene expression platforms. Figure 3c, d. Peripheral blood progesterone ( n = 187) and estrogen ( n = 159) data plotted against the molecular staging model cycle stage showed expected typical menstrual cycle-stage distribution. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: A molecular staging model for accurately dating the endometrial biopsy

doi: 10.1038/s41467-023-41979-z

Figure Lengend Snippet: Figure 3a. For endometrial secretory samples, POD predicted from the secretory molecular staging model was compared against the full molecular staging model. Note, POD 1 is approximately 58% of the way through the cycle. Figure 3b. Illumina HT-12 microarray data were also available from 198 endometrial samples used to generate the molecular staging model. A validation study was run comparing NGS vs Illumina data. The molecular staging model results showed a strong correlation when comparing the 2 different gene expression platforms. Figure 3c, d. Peripheral blood progesterone ( n = 187) and estrogen ( n = 159) data plotted against the molecular staging model cycle stage showed expected typical menstrual cycle-stage distribution. Source data are provided as a Source Data file.

Article Snippet: To further explore the effects of aging on endometrial gene expression, an additional n = 87 Illumina microarray endometrial samples from GSE141549 were analysed and combined with our RNA-seq differential expression results as part of a meta-analysis.

Techniques: Microarray, Expressing

Figure 4a. PCA plot using 266 endometrial samples coloured to show the molecular staging model cycle stage. The PCA plot has a characteristic pattern with the samples in cyclic pattern corresponding to approximate cycle stage order. Figure 4b. PCA plot using Illumina microarray data from GSE141549 , with samples identified as menstrual, proliferative, or secretory by the authors. Note significant mixing of proliferative samples with menstrual and secretory ones. Figure 4c. The same PCA plot using data from GSE141549 with cycle stage assigned by the molecular staging model. Note minimal overlap between different molecular staging model cycle stages. Figure 4d. PCA plot using RNA-seq data from GSE65099 with samples identified as LH + 6 to LH + 10 as reported in the study. Figure 4e. The same PCA plot using data from GSE65099 with cycle stage assigned by the molecular staging model. Note reassignment of 2 outlying samples on the PCA plot as proliferative and not secretory. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: A molecular staging model for accurately dating the endometrial biopsy

doi: 10.1038/s41467-023-41979-z

Figure Lengend Snippet: Figure 4a. PCA plot using 266 endometrial samples coloured to show the molecular staging model cycle stage. The PCA plot has a characteristic pattern with the samples in cyclic pattern corresponding to approximate cycle stage order. Figure 4b. PCA plot using Illumina microarray data from GSE141549 , with samples identified as menstrual, proliferative, or secretory by the authors. Note significant mixing of proliferative samples with menstrual and secretory ones. Figure 4c. The same PCA plot using data from GSE141549 with cycle stage assigned by the molecular staging model. Note minimal overlap between different molecular staging model cycle stages. Figure 4d. PCA plot using RNA-seq data from GSE65099 with samples identified as LH + 6 to LH + 10 as reported in the study. Figure 4e. The same PCA plot using data from GSE65099 with cycle stage assigned by the molecular staging model. Note reassignment of 2 outlying samples on the PCA plot as proliferative and not secretory. Source data are provided as a Source Data file.

Article Snippet: To further explore the effects of aging on endometrial gene expression, an additional n = 87 Illumina microarray endometrial samples from GSE141549 were analysed and combined with our RNA-seq differential expression results as part of a meta-analysis.

Techniques: Microarray, RNA Sequencing Assay